IL-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance

Journal of Immunology

Volumn 166, Issue 9, 2001, Pages 5619-5628

  Li, W ^a   Lu, L ^a   Wang, Z ^a   Wang, L ^a   Fung, J J ^a   Thomson, A W ^a   Qian, S ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; FLT3 LIGAND; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

EID: 0035341021     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.9.5619     Document Type: Article

References (67)

1. Murine liver allograft transplantation: Tolerance and donor cell chimerism
2. Soluble HLA antigens in the circulation of liver graft recipients
3. Immunosuppressive effect of experimental liver allografts
4. Cell migration and chimerism after whole organ transplantation: The basis of graft acceptance
5. Growth of donor-derived dendritic cells from the bone marrow of liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor
6. Are dendritic cells the key to liver transplant tolerance?
7. Isolation, phenotype, and allostimulatory activity of mouse liver dendritic cells
8. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen
9. Microchimerism, dendritic cell progenitors and transplantation tolerance
10. GM-CSF stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival
11. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation
12. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo
13. Cloning of the human homologue of the murine Flt3 ligand: A growth factor for early hematopoitic progenitor cells
14. +) dendritic cells: Association with conversion from liver transplant tolerance to acute rejection
15. Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity
16. Apoptosis within spontaneously accepted mouse liver allografts: Evidence for deletion of cytotoxic T cells and implications for tolerance induction
17. Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance
18. Interleukin-12, a proinflammatory cytokine with immuno-regulatory functions that bridge innate resistance and antigen-specific adaptive immunity
19. Interleukin-12
20. Mechanisms of IFN-γ production by natural killer cell stimulatory factor (NKSF/IL-12): Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2
21. + T lymphocytes, and NK cells
22. Natural killer cell stimulatory factor interleukin 12 (IL-12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells
23. Regulation of human cytolytic lymphocyte responses by interleukin-12
24. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming
25. Antitumor and antimetastatic activity of interleukin 12 against murine tumors
26. Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells
27. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer
28. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease
29. IL-12 is a central mediator of acute graft-versus-host disease in mice
30. Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection
31. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection: Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity
32. CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection
33. Orthotopic liver transplantation in mice
34. In vivo administration of Flt3 ligand results in generation of large numbers of dendritic cells in the lymphoid tissue of mice
35. Secondary response to Listeria infection requires IFN-γ but is partially independent of IL- 12
36. + lymphoid-related dendritic cells
37. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
38. Single step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction
39. Donor pretreatment with Flt3 ligand augments anti-donor CTL, NK and LAK cell activities within liver allografts and alters the pattern of intragraft apoptotic activity
40. IL-12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 cross-linking and CD3/TCR activation or by IL-2 deprivation
41. + T cells from human immunodeficiency virus-infected persons
42. Extinction of IL-12 signaling promotes Fas-mediated apoptosis of antigen-specific T cells
43. Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis
44. High dose oral tolerance in ovalbumin TCR-transgenic mice: Systemic neutralization of IL-12 augments TGF-β secretion and T cell apoptosis
45. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice
46. Effects of IL-12 on helper T cell-dependent immune responses in vivo
47. + T lymphocytes
48. + T cells through IL-12 produced by Listeria-induced macrophages
49. IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni
50. IL-12 modulation of T helper responses to the filarial helminth. Brugia malayi
51. In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during acquired immunodeficiency syndrome (MAIDS)
52. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ
53. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection
54. IL-12-deficient mice are defective in IFNγ production and type I cytokine responses
55. Cells mediating allograft rejection
56. Cellular basis of skin allograft rejection: An in vivo model of immune-mediated tissue destruction
57. Alloantigen-reactive Th1 development in IL-12-deficient mice
58. Systemic administration of cellular interleukin-10 exacerbates cardiac allograft rejection in mice
59. Differential effects of exogenous interleukin-10 on cardiac allograft survival: Inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function
60. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients
61. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo
62. Interleukin 12 alters the isotype-restricted antibody response of mice to hen egg-white lysozyme
63. Interleukin-12 acts as an adjuvant for humoral immunity through interferon-γ-dependent and -independent mechanisms
64. Direct binding of IL-12 to human and murine B lymphocytes
65. An in vitro model for T cell-independent induction of humoral immunity: A requirement for NK cells
66. The role of NK cells during in vivo antigen-specific antibody responses
67. Blocking both signal I and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance